Lung clearance of intratracheally instilled 99mTc‐tobramycin using pulmonary surfactant as vehicle
- 1 March 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (5) , 1091-1096
- https://doi.org/10.1038/sj.bjp.0702405
Abstract
1. The use of pulmonary exogenous surfactant as a vehicle for intratracheally administered antibiotics to improve local antimicrobial therapy has been proposed. The present study investigated lung clearance rates in the rat of intratracheally instilled technetium labelled tobramycin with and without the addition of surfactant to the antibiotic solution. 2. The influence of surfactant on 99mTc-tobramycin lung clearance rates was studied dynamically with a gamma-camera in anaesthetized spontaneously breathing animals and in mechanically ventilated animals. 3. The results show that instillation of 99mTc-tobramycin with use of surfactant as vehicle significantly increases 99mTc-tobramycin lung clearance compared to instillation of 99mTc-tobramycin solution alone (P=0.006 between the two spontaneously breathing groups of animals and P=0.02 between the two ventilated groups of animals, ANOVA for repeated time measurements). The half life (t1/2) of composite clearance curves in spontaneous breathing animals was 147 min for animals receiving 99mTc-tobramycin versus 61 min for animals receiving 99mTc-tobramycin with surfactant. In mechanically ventilated animals this was 163 min versus 51 min, respectively. 4. It is concluded that exogenous surfactant, used as vehicle for intratracheally instilled 99mTc-tobramycin, increases lung clearance rate of 99mTc-tobramycin in rats.Keywords
This publication has 24 references indexed in Scilit:
- Exogenous Surfactant Enhances the Delivery of Recombinant Adenoviral Vectors to the LungHuman Gene Therapy, 1997
- Pulmonary technetium-99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injuryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycinAntimicrobial Agents and Chemotherapy, 1995
- Absolute Bioavailability and Absorption Characteristics of Aerosolized Tobramycin in Adults with Cystic FibrosisThe Journal of Clinical Pharmacology, 1994
- The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosisRespiratory Medicine, 1994
- Efficacy of Aerosolized Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1993
- Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance aloneCritical Care Medicine, 1993
- Labelling and quality control of gentamycin with99mTc and biodistributionJournal of Radioanalytical and Nuclear Chemistry, 1988
- Binding and diffusion characteristics of 14C EDTA and 99mTc DTPA in respiratory tract mucus glycoprotein from patients with chronic bronchitis.Thorax, 1988
- Aspects of the Pharmacology and Toxicology of Tobramycin in Animals and HumansThe Journal of Infectious Diseases, 1976